We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01308294
Brief Title: Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients (LAG-3/IMP321)

First Submitted : March 3, 2011
First Submitted that Met QC Criteria : March 3, 2011
First Posted : March 4, 2011 (Estimate)

Last Update Submitted : October 14, 2014
Last Update Submitted that Met QC Criteria : October 14, 2014
Last Update Posted : October 15, 2014 (Estimate)